
Vaccine Makers Push Back as U.S. Panel Moves Away from Universal Hepatitis B Shots for Newborns
Vaccine manufacturers and public health experts are voicing strong concern after a U.S. advisory panel voted to end its long-standing recommendation that all newborns receive a hepatitis B vaccine at birth — a policy shift critics warn could erode decades…


